Multiple Sclerosis

Multiple Sclerosis (MS)

Multiple sclerosis is a common neurodegenerative disorder affecting the central nervous system. This is one of the leading non traumatic disability in young adults. This condition results from the loss of the insulating covering (myelin) of nerves in the brain and/or spinal cord. This loss of nerve covering results affects the brain and spinal cord ability to transmit signals resulting in physical and cognitive disability. The exact cause is not clear, however it is related to either improper myelin formation or the immune system attacking the nerve covering (myelin).
Multiple sclerosis can be diagnosed at any age, however, is most diagnosed between the ages of 20-35 year of ages. The diagnosis is usually symptom based supported by specific MRI findings and cerebrospinal fluid markers.
Rehabilitation interventions should be considered early for optimizing functional capacity and maintaining independence. Studies have shown, in addition to pharmacologic disease modifying therapy, early rehab intervention optimizes functional capacity and reduces risk for loss of independence. Early rehabilitation has been proven to reduce disability, participation and quality of life despite disease progression.